XK and infection: To assess the protection from disease in vivo afforded by our NA-F2A-HA DNA plasmid, we challenged prime/boosted mice with WT A/Texas/37/2024 virus in a BSL-3 biocontainment facility and followed body weight, clinical scores, and viral load in tissues over the course of infection (Fig. 3A).